Real-time enrollment status for this pancreatic ductal adenocarcinoma (pdac) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:46 PM UTC
| NCT Number | NCT07644559 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma (PDAC) |
| Phase | PHASE2 |
| Target Enrollment | 185 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Verastem, Inc. |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT07644559 is currently recruiting participants. This phase2 study for pancreatic ductal adenocarcinoma (pdac) is actively seeking new participants at 25 locations across the United States. The study is sponsored by Verastem, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07644559 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07644559 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.